Innovation and Commercialisation in the Biopharmaceutical Industry: Creating and Capturing Value

Front Cover
Edward Elgar Publishing, Jan 1, 2010 - Business & Economics - 336 pages
0 Reviews
The processes of discovery, testing and distribution of new medicines have undergone radical change in recent decades, from a focus on small molecule drugs to biomedicine and related technologies. Bruce Rasmussen very effectively draws upon modern theorie
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

1 Overview
1
PART I Firms networks and business models
13
Introduction to Part I
15
2 Lessons from the modern theory of the firm
18
3 Open innovation and the networked firm
31
4 The business model
42
Concluding comments
56
new foundations for biopharmaceuticals
59
9 An overview of trends in biomedical alliances
125
10 Trends in biopharmaceutical alliances for key business models
143
PART IV Four case studies
157
11 Case studies in biopharmaceutical business models
159
12 Biopharmaceutical value chains
199
a case study in the development of a platform technology
209
Starpharma
239
15 Creating and capturing value in the biopharmaceutical sector
257

5 Drug discovery and development technologies
61
process uncertainties and cost
76
diverse business models
85
structure and business models
87
8 Biopharmaceutical company business models
108
16 Implications for industry structure
285
References
290
Index
313
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information